Skip to main content

Table 3 Risk factor for case-fatality: logistic regression analysis

From: The pattern and predictors of mortality of HIV/AIDS patients with neurologic manifestation in Ethiopia: a retrospective study

Factor n % Unadjusted
OR(95% CI)
Adjusted
OR(95% CI)
Age(year) < 40 113 44.3 1.00 1.00
  ≥ 40 43 46.7 1.10(0.684-1.779) 1.033(0.529-2.018)
Sex Male 77 43.8 1.00 1.00
  female 79 46.2 1.10(0.723-1.686) 1.033(0.566-1.887)
Address Addis Ababa 133 50.8 1.00 1.00
  Outside Addis Ababa 23 27.1 0.360(0.210-0.615) 0.282(0.127-0.630)
History of ART
treatment
Yes 21 38.9 1.00 1.00
  No 135 46.1 1.343(0.742-2.430) 1.1(0.506-2.393)
Cotrimoxazole
(prophylaxis)
Yes 8 53.3 1.00 1.00
  No 148 44.6 0.704(0.249-1.986) 0.992(0.266-3.705)
Altered sensorium Yes 99 52.9 1.00 1.00
  No 57 35.6 0.492(0.319-0.758) 0.514(0.288-0.916)
Seizure Yes 65 54.6 1.00 1.00
  No 91 39.9 0.552(0.353-0.863) 0.519(0.288-0.935)
Clinical stage of HIV infection Stage iii 3 20 1.00 1.00
  Stage iv 153 46.1 3.419(0.947-12.339) 2.069(0.370-11.562)
CD4 count(/mm3) < 200 85 42.3 1.00 1.00
  ≥ 200 6 26.1 0.482(0.182-1.273) 0.572(0.205-1.595)
  1. ART antiretroviral treatment, HIV human immunodeficiency virus CD 4 cluster of differentiation 4